BioNTech Accounts Payable from 2010 to 2024

BNTX Stock  USD 113.51  0.43  0.38%   
BioNTech Accounts Payable yearly trend continues to be fairly stable with very little volatility. Accounts Payable is likely to outpace its year average in 2024. Accounts Payable is the amount BioNTech SE owes to suppliers or vendors for products or services received but not yet paid for. It represents BioNTech's short-term liabilities. View All Fundamentals
 
Accounts Payable  
First Reported
2018-12-31
Previous Quarter
881.5 M
Current Value
762.6 M
Quarterly Volatility
223.2 M
 
Covid
Check BioNTech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioNTech's main balance sheet or income statement drivers, such as Tax Provision of 243 M, Net Interest Income of 367.2 M or Interest Income of 375.5 M, as well as many indicators such as Price To Sales Ratio of 5.69, Dividend Yield of 0.011 or PTB Ratio of 1.19. BioNTech financial statements analysis is a perfect complement when working with BioNTech Valuation or Volatility modules.
  
Check out the analysis of BioNTech Correlation against competitors.

Latest BioNTech's Accounts Payable Growth Pattern

Below is the plot of the Accounts Payable of BioNTech SE over the last few years. An accounting item on the balance sheet that represents BioNTech obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of BioNTech SE are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. BioNTech's Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in BioNTech's overall financial position and show how it may be relating to other accounts over time.
Accounts Payable10 Years Trend
Slightly volatile
   Accounts Payable   
       Timeline  

BioNTech Accounts Payable Regression Statistics

Arithmetic Mean90,025,533
Geometric Mean28,624,766
Coefficient Of Variation140.76
Mean Deviation98,929,644
Median20,498,000
Standard Deviation126,722,908
Sample Variance16058.7T
Range365.5M
R-Value0.83
Mean Square Error5320T
R-Squared0.69
Significance0.0001
Slope23,578,261
Total Sum of Squares224821.7T

BioNTech Accounts Payable History

2024371.7 M
2023354 M
2022204.1 M
2021160 M
2020102.3 M
201920.5 M
201841.7 M

About BioNTech Financial Statements

BioNTech investors use historical fundamental indicators, such as BioNTech's Accounts Payable, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in BioNTech. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Accounts Payable354 M371.7 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for BioNTech Stock Analysis

When running BioNTech's price analysis, check to measure BioNTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioNTech is operating at the current time. Most of BioNTech's value examination focuses on studying past and present price action to predict the probability of BioNTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioNTech's price. Additionally, you may evaluate how the addition of BioNTech to your portfolios can decrease your overall portfolio volatility.